对难以治疗的类风湿性关节炎患者进行了为期五年的随访
Satoshi Takanashi1, Tsutomu Takeuchi1,2, Yuko Kaneko1
1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Rheumatology (Oxford, England)
|June 9, 2024
概括
治疗修改改善了难以治疗的类风湿性关节炎 (D2T RA) 的结果. 然而,并发症和葡萄糖皮质类药物使用与D2T RA患者的死亡率有关.
科学领域:
- 类风湿病学 类风湿病学
- 临床医学 临床医学
- 纵向研究 纵向研究
背景情况:
- 难以治疗的类风湿性关节炎 (D2T RA) 提出了重大管理挑战.
- 了解长期结果对于优化患者护理至关重要.
研究的目的:
- 调查D2T RA患者的长期结果.
- 为了确定在D2T RA中预测解决或死亡的因素.
主要方法:
- 在2018年确定D2T RA的173名患者的队列被跟踪到2023年.
- 根据结果对患者进行了分层:已解决的D2T RA,持久的D2T RA和死亡率.
- 分析了包括治疗变化,耐药性,并发症和社会经济地位在内的预测因素.
主要成果:
- 在150名分析的患者中,45%的患者实现了D2T RA解决,50%的患者患有持续的D2T RA,5%的患者死亡.
- 已解决的D2T RA与年轻的年龄,更频繁的治疗变化以及使用IL-6受体抑制剂有关.
- 多种药物耐药性影响了分辨率,而类风湿性疾病并发症指数和高剂量葡萄糖皮质激素独立预测死亡率.
结论:
- 治疗修改,包括IL-6抑制剂等先进疗法,可以导致D2TRA解决.
- 并发症和高剂量葡萄糖皮质激素的使用是D2T RA中死亡率的重要风险因素.
- 对管理并发病症和优化治疗策略的进一步研究是有必要的.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...


